The flu vaccine helps prevent flu cases from getting more severe and requiring hospitalisation. Every year, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee decides which viruses to use for the upcoming season’s flu vaccine. Data collected by the FDA, World Health Organization, US Centers for Disease Control and Prevention (CDC) and other partners on which flu strains are circulating around the world inform that committee’s decision. (The committee’s meeting to discuss influenza vaccine strains for the 2025-2026 influenza season was cancelled.)According to the CDC, during seasons when the flu vaccine strains and the circulating flu strains match, the vaccine “has been shown to reduce the risk of having to go to the doctor with flu by 40% to 60%”.Robert H Hopkins Jr, the medical director of the National Foundation for Infectious Diseases, said the Cleveland Clinic study does not evaluate the primary benefit for getting vaccinated against influenza: reducing one’s risk for severe illness, hospitalisation and death
CSL Price at posting:
$245.45 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)